Oral contraceptives: Current status

被引:41
作者
Burkman, RT
机构
[1] Baystate Med Ctr, Springfield, MA USA
[2] Tufts Univ, Sch Med, Boston, MA 02111 USA
关键词
D O I
10.1097/00003081-200103000-00010
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
During the past four decades, oral contraceptives have remained a safe and effective method of birth control. Reductions in the estrogen and progestin dosages have significantly decreased the incidence of cardiovascular complications. The association between oral contraceptives and breast cancer appears to be primarily because of detection bias or possibly a promotional effect. Despite the changes in formulation, the problems related to side effects have not been totally solved. Because compliance and successful use is strongly affected by side effects, improvement in this area is probably the biggest challenge faced by developers of oral contraceptives, it is also clear that there are a growing number of significant noncontraceptive benefits that accrue in oral contraceptive users. Unfortunately, many women do not know about these benefits. Thus, one of the issues that providers need to continue to address is how to provide better information about oral contraceptives and contraception in general to patients.
引用
收藏
页码:62 / 72
页数:11
相关论文
共 29 条
  • [1] BURKMAN RT, 1996, ADV OBS GYN, V3, P103
  • [2] Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5
  • [3] Charreau I, 1993, Eur J Cancer Prev, V2, P147, DOI 10.1097/00008469-199303000-00007
  • [4] DAVIS A, 2000, OBSTET GYNECOL, V95, pS84
  • [5] Bone-sparing properties of oral contraceptives
    DeCherney, A
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (01) : 15 - 20
  • [6] Oral contraceptive use and risk of colorectal cancer
    Fernandez, E
    La Vecchia, C
    Franceschi, S
    Braga, C
    Talamini, R
    Negri, E
    Parazzini, F
    [J]. EPIDEMIOLOGY, 1998, 9 (03) : 295 - 300
  • [7] Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer
    Gabrick, DM
    Hartmann, LC
    Cerhan, JR
    Vierkant, RA
    Therneau, TM
    Vachon, CM
    Olson, JE
    Couch, FJ
    Anderson, KE
    Pankratz, VS
    Sellers, TA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (14): : 1791 - 1798
  • [8] ORAL-CONTRACEPTIVE ESTROGEN DOSE AND THE RISK OF DEEP VENOUS THROMBOEMBOLIC DISEASE
    GERSTMAN, BB
    PIPER, JM
    TOMITA, DK
    FERGUSON, WJ
    STADEL, BV
    LUNDIN, FE
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 133 (01) : 32 - 37
  • [9] HANKINSON SE, 1992, OBSTET GYNECOL, V80, P708
  • [10] *INT FED FERT SOC, 1999, FERTIL STERIL, V71, pS1